hydroxyzine HCL

DRUG2 trials

Conditions

Anxiety in Those Patients With Anorexia NervosaCarcinoma In SituCervical Intraepithelial NeoplasiaEating Disorder Not Otherwise Specified, BMI (<=18)Papillomavirus InfectionsVulvar DiseasesVulvar Neoplasms

Phase 1

E7 TCR T Cells for Human Papillomavirus-Associated Cancers

CompletedNCT02858310

National Cancer Institute (NCI)Carcinoma In Situ, Cervical Intraepithelial Neoplasia, Papillomavirus Infections +2

Start: 2017-01-27End: 2025-07-02Updated: 2026-03-09

Phase 4

Does Hydroxyzine Decrease Anxiety in Underweight Patients Diagnosed With an Eating Disorder

WithdrawnNCT01372670

HealthPartners InstituteAnxiety in Those Patients With Anorexia Nervosa, Eating Disorder Not Otherwise Specified, BMI (<=18)

Start: 2012-01-31End: 2013-04-30Updated: 2016-11-15

2021-02-08258 citations

Safety and clinical activity of gene-engineered T-cell therapy targeting HPV-16 E7 for epithelial cancers.

Journal of Clinical Oncology2020-05-2020 citations

Engineered t cells targeting E7 mediate regression of human papillomavirus cancers in a murine model.

Journal of Clinical Oncology2018-05-205 citations

Engineered T cells targeting E7 mediate regression of human papillomavirus cancers in a murine model

JCI Insight2018-04-18159 citations

hydroxyzine HCL

Sponsors

Conditions

Phase 1

Phase 4

Related Papers